A collaborative platform for novel compound identification - characterization of designer phencyclidines (PCPs) POXP, PTHP, and P2AP

Published

May 25, 2023

Author(s)

Edward Sisco, Aaron Urbas

Abstract

With the sustained prevalence and introduction of emerging drugs throughout the world there is a need for continued development and maintenance of platforms that enable rapid identification and characterization of unknown compounds. To complement existing efforts, a collaborative platform between the National Institute of Standards and Technology (NIST) and practicing forensic agencies is being deployed which enables laboratories to leverage techniques and expertise that may not exist at their facilities. Using this approach, unknown compounds are identified and characterized using a suite of analytical tools to obtain (1) a rapid preliminary identification followed by (2) a more complete characterization and confirmation of the preliminary identification. To demonstrate this platform, the characterization of three previously unreported analogs of phencyclidine (PCP) – POXP, PTHP, and P2AP – are described. A preliminary identification of the three substances was obtained using direct analysis in real time mass spectrometry (DART-MS) with confirmation by nuclear magnetic resonance (NMR) spectroscopy, gas chromatography mass spectrometry (GC–MS) and gas chromatography flame ionization detection (GC-FID).

Citation

Forensic Chemistry

Pub Type

Journals

Download Paper

https://doi.org/10.1016/j.forc.2023.100505

Local Download

Keywords

Emerging Drugs, Novel Psychoactive Substances, Phencyclidine, PCP, Identification

Citation

Sisco, E. and Urbas, A. (2023), A collaborative platform for novel compound identification - characterization of designer phencyclidines (PCPs) POXP, PTHP, and P2AP, Forensic Chemistry, [online], https://doi.org/10.1016/j.forc.2023.100505, https://tsapps.nist.gov/publication/get_pdf.cfm?pub_id=934907 (Accessed May 16, 2024)